ST. ALPHONSUS MEDICAL CENTER - NAMP — History
CCN 130013 | 3-year financial timeline | COVID resilience: 55/100
🛡️ Public data only — no PHI permitted on this instance.
$263M
Latest Revenue (FY2022)
+8.3%
Revenue CAGR (3yr)
15.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $224M | $234M | $263M | +12.3% | +8.3% |
| Operating Expenses | $182M | $213M | $223M | +4.7% | +10.8% |
| Operating Margin | 19.0% | 9.1% | 15.2% | +67.6% | -10.5% |
| Net Income | $43M | $21M | $40M | +88.3% | -3.0% |
| Licensed Beds | 96 | 96 | 96 | +0.0% | +0.0% |
| Total Patient Days | 22,478 | 25,983 | 27,588 | +6.2% | +10.8% |
| Medicare Day % | 24% | 24% | 24% | +2.0% | -0.3% |
| Medicaid Day % | 22% | 22% | 23% | +4.6% | +2.4% |
COVID Impact & Recovery
Resilience Score: 55/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.3% ($224M → $263M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.3%
This Hospital
+7.6%
State Avg
Latest Margin
15.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $283M | 13.3% |
| FY2024 (proj) | $302M | 11.4% |
| FY2025 (proj) | $322M | 9.5% |